Anthem Blue Cross Blue Shield of Colorado prior authorization, page 51

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0171UTargeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms, DNA analysis, 23 genes, interrogation for sequencColorado Prior Authorization List, Pg 121 Original policy
0172UOncology (solid tumor as indicated by the label), somatic mutation analysis of BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) and analysis of homolColorado Prior Authorization List, Pg 121 Original policy
0173UPsychiatry (ie, depression, anxiety), genomic analysis panel, includes variant analysis of 14 geneColorado Prior Authorization List, Pg 121 Original policy
0174UOncology (solid tumor), mass spectrometric 30 protein targets, formalin-fixed paraffin-embedded tissue, prognostic and predictive algorithm reported as likely, unlikely, or unColorado Prior Authorization List, Pg 121 Original policy
0175UPsychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genesColorado Prior Authorization List, Pg 121 Original policy
0176UCytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)Colorado Prior Authorization List, Pg 121 Original policy
0177UOncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported asColorado Prior Authorization List, Pg 121 Original policy
0179UOncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knoColorado Prior Authorization List, Pg 121 Original policy
0186TSuprachoroidal delivery of pharmacologic agent (does not include supply of medication)Colorado Prior Authorization List, Pg 121 Original policy
0191TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; internal approach, into the trabecular meshworkColorado Prior Authorization List, Pg 121 Original policy
0192TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; external approachColorado Prior Authorization List, Pg 121 Original policy
0200TPercutaneous sacral augmentation (sacroplasty), unilateral injection(s), including the use of a balloon or mechanical device, when used, 1 or more needlesColorado Prior Authorization List, Pg 121 Original policy
0201TPercutaneous sacral augmentation (sacroplasty), bilateral injections, including the use of a balloon or mechanical device, when used, 2 or more needlesColorado Prior Authorization List, Pg 121 Original policy
0202TPosterior vertebral joint(s) arthroplasty (e.g., facet joint[s] replacement) including facetectomy, laminectomy, foraminColorado Prior Authorization List, Pg 121 Original policy
0203UAutoimmune (inflammatory bowel disease), mRNA, gene expression profiling by quantitative RT-PCR, 17 genes (15 target and 2 reference genes), whole blood, reported as a continuColorado Prior Authorization List, Pg 121 Original policy
0205UOphthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negativColorado Prior Authorization List, Pg 121 Original policy
0206UNeurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA, cColorado Prior Authorization List, Pg 121 Original policy
0207TEvacuation of meibomian glands, automated, using heat and intermittent pressure, unilateralColorado Prior Authorization List, Pg 122 Original policy
0209UCytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalitiesColorado Prior Authorization List, Pg 122 Original policy
0211UOncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copyColorado Prior Authorization List, Pg 122 Original policy
0212URare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandColorado Prior Authorization List, Pg 122 Original policy
0213TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0213URare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandColorado Prior Authorization List, Pg 122 Original policy
0214TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0214URare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandeColorado Prior Authorization List, Pg 122 Original policy
0215TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0215URare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandeColorado Prior Authorization List, Pg 122 Original policy
0216TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0216UNeurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansionsColorado Prior Authorization List, Pg 122 Original policy
0217TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0217UNeurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and vaColorado Prior Authorization List, Pg 122 Original policy
0218TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiColorado Prior Authorization List, Pg 122 Original policy
0218UNeurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood orColorado Prior Authorization List, Pg 122 Original policy
0221TPlacement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; lumbarColorado Prior Authorization List, Pg 122 Original policy
0222TPlacement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; each additionalColorado Prior Authorization List, Pg 122 Original policy
0228TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; single levelColorado Prior Authorization List, Pg 122 Original policy
0228UOncology (prostate), multianalyte molecular profile by photometric detection of macromolecules adsorbed on nanosponge array slides with machine learning, utilizing first morniColorado Prior Authorization List, Pg 123 Original policy
0229TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; each additional level (List separately in addition to cColorado Prior Authorization List, Pg 123 Original policy
0229UBCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysisColorado Prior Authorization List, Pg 123 Original policy
0230TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; single levelColorado Prior Authorization List, Pg 123 Original policy
0230UAR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), full sequence analysis, including small sequence changes in exonicColorado Prior Authorization List, Pg 123 Original policy
0231TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; each additional level (List separately in addition to codeColorado Prior Authorization List, Pg 123 Original policy
0231UCACNA1A (calcium voltage-gated channel subunit alpha 1A) (eg, spinocerebellar ataxia), full gene analysis, including small sequence changes in exonic and intronic regions, delColorado Prior Authorization List, Pg 123 Original policy
0232TInjection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation when performedColorado Prior Authorization List, Pg 123 Original policy
0232UCSTB (cystatin B) (eg, progressive myoclonic epilepsy type 1A, Unverricht- Lundborg disease), full gene analysis, including small sequence changes in exonic and intronic regionColorado Prior Authorization List, Pg 123 Original policy
0233UFXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expaColorado Prior Authorization List, Pg 123 Original policy
0234UMECP2 (methyl CpG binding protein 2) (eg, Rett syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobileColorado Prior Authorization List, Pg 123 Original policy
0235UPTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome), full gene analysis, including small sequence changes in exonic and intronic regionsColorado Prior Authorization List, Pg 123 Original policy
0236USMN1 (survival of motor neuron 1, telomeric) and SMN2 (survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy) full gene analysis, including small sequence chanColorado Prior Authorization List, Pg 123 Original policy
0237UCardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia), genomic sequence analysis panelColorado Prior Authorization List, Pg 123 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.